Molecular mechanisms of carbapenem resistance in enterobacter cloacae clinical isolates from Korea and clinical outcome

Yangsoon Lee, Heekyeong Choi, Jong Hwa Yum, Girung Kang, Il Kwon Bae, Seokhoon Jeong, Kyungwon Lee

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We investigated the molecular mechanisms of carbapenem resistance in clinical isolates of Enterobacter cloacae and their clinical characteristics. Nonreplicable E. cloacae isolates were recovered from six cancer patients and one patient with liver cirrhosis at a tertiary-care hospital in Korea between 2002 and 2009. Two patients who were considered to have a true infection caused by these microorganisms have died. All isolates produced AmpC β-lactamases, including ACT-1, ACT-2, MIR-3 and DHA-1, and CTX-M- or SHV-type extended-spectrum β-lactamase. Two isolates produced plasmid-borne VIM-2 carbapenemase. All probes specific for blaAmpC genes hybridized with I-CeuI chromosomal fragments were also recognized by a probe specific for 16S rDNA, suggesting a chromosomal location. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that a major outer membrane protein, OmpF, was absent in all isolates. PFGE of XbaI-digested DNA were considered to be unrelated. The results of our study suggest that the chromosomal AmpC β-lactamase with impermeability in E. cloacae clinical isolates implicated in reduced carbapenem susceptibility. Although carbapenem-resistant E. cloacae isolates were isolated in a few patients in our study, the clinical outcomes were grave. Therefore, the patients colonized or infected by carbapenemresistant E. cloacae isolates should gain attention of antibiotic therapy.

Original languageEnglish
Pages (from-to)281-286
Number of pages6
JournalAnnals of Clinical and Laboratory Science
Volume42
Issue number3
Publication statusPublished - 2012 Nov 15

Fingerprint

Enterobacter cloacae
Carbapenems
Korea
Ribosomal DNA
Electrophoresis
Sodium Dodecyl Sulfate
Microorganisms
Liver
Membrane Proteins
Plasmids
Genes
Anti-Bacterial Agents
Tertiary Healthcare
Tertiary Care Centers
Liver Cirrhosis
DNA
Polyacrylamide Gel Electrophoresis
Outcome Assessment (Health Care)
Infection
Neoplasms

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Microbiology
  • Pathology and Forensic Medicine
  • Immunology
  • Hematology
  • Molecular Biology
  • Clinical Biochemistry
  • Medical Laboratory Technology

Cite this

@article{9e591d7a9d54418d928cfdb13a8f6422,
title = "Molecular mechanisms of carbapenem resistance in enterobacter cloacae clinical isolates from Korea and clinical outcome",
abstract = "We investigated the molecular mechanisms of carbapenem resistance in clinical isolates of Enterobacter cloacae and their clinical characteristics. Nonreplicable E. cloacae isolates were recovered from six cancer patients and one patient with liver cirrhosis at a tertiary-care hospital in Korea between 2002 and 2009. Two patients who were considered to have a true infection caused by these microorganisms have died. All isolates produced AmpC β-lactamases, including ACT-1, ACT-2, MIR-3 and DHA-1, and CTX-M- or SHV-type extended-spectrum β-lactamase. Two isolates produced plasmid-borne VIM-2 carbapenemase. All probes specific for blaAmpC genes hybridized with I-CeuI chromosomal fragments were also recognized by a probe specific for 16S rDNA, suggesting a chromosomal location. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that a major outer membrane protein, OmpF, was absent in all isolates. PFGE of XbaI-digested DNA were considered to be unrelated. The results of our study suggest that the chromosomal AmpC β-lactamase with impermeability in E. cloacae clinical isolates implicated in reduced carbapenem susceptibility. Although carbapenem-resistant E. cloacae isolates were isolated in a few patients in our study, the clinical outcomes were grave. Therefore, the patients colonized or infected by carbapenemresistant E. cloacae isolates should gain attention of antibiotic therapy.",
author = "Yangsoon Lee and Heekyeong Choi and Yum, {Jong Hwa} and Girung Kang and Bae, {Il Kwon} and Seokhoon Jeong and Kyungwon Lee",
year = "2012",
month = "11",
day = "15",
language = "English",
volume = "42",
pages = "281--286",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "3",

}

Molecular mechanisms of carbapenem resistance in enterobacter cloacae clinical isolates from Korea and clinical outcome. / Lee, Yangsoon; Choi, Heekyeong; Yum, Jong Hwa; Kang, Girung; Bae, Il Kwon; Jeong, Seokhoon; Lee, Kyungwon.

In: Annals of Clinical and Laboratory Science, Vol. 42, No. 3, 15.11.2012, p. 281-286.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecular mechanisms of carbapenem resistance in enterobacter cloacae clinical isolates from Korea and clinical outcome

AU - Lee, Yangsoon

AU - Choi, Heekyeong

AU - Yum, Jong Hwa

AU - Kang, Girung

AU - Bae, Il Kwon

AU - Jeong, Seokhoon

AU - Lee, Kyungwon

PY - 2012/11/15

Y1 - 2012/11/15

N2 - We investigated the molecular mechanisms of carbapenem resistance in clinical isolates of Enterobacter cloacae and their clinical characteristics. Nonreplicable E. cloacae isolates were recovered from six cancer patients and one patient with liver cirrhosis at a tertiary-care hospital in Korea between 2002 and 2009. Two patients who were considered to have a true infection caused by these microorganisms have died. All isolates produced AmpC β-lactamases, including ACT-1, ACT-2, MIR-3 and DHA-1, and CTX-M- or SHV-type extended-spectrum β-lactamase. Two isolates produced plasmid-borne VIM-2 carbapenemase. All probes specific for blaAmpC genes hybridized with I-CeuI chromosomal fragments were also recognized by a probe specific for 16S rDNA, suggesting a chromosomal location. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that a major outer membrane protein, OmpF, was absent in all isolates. PFGE of XbaI-digested DNA were considered to be unrelated. The results of our study suggest that the chromosomal AmpC β-lactamase with impermeability in E. cloacae clinical isolates implicated in reduced carbapenem susceptibility. Although carbapenem-resistant E. cloacae isolates were isolated in a few patients in our study, the clinical outcomes were grave. Therefore, the patients colonized or infected by carbapenemresistant E. cloacae isolates should gain attention of antibiotic therapy.

AB - We investigated the molecular mechanisms of carbapenem resistance in clinical isolates of Enterobacter cloacae and their clinical characteristics. Nonreplicable E. cloacae isolates were recovered from six cancer patients and one patient with liver cirrhosis at a tertiary-care hospital in Korea between 2002 and 2009. Two patients who were considered to have a true infection caused by these microorganisms have died. All isolates produced AmpC β-lactamases, including ACT-1, ACT-2, MIR-3 and DHA-1, and CTX-M- or SHV-type extended-spectrum β-lactamase. Two isolates produced plasmid-borne VIM-2 carbapenemase. All probes specific for blaAmpC genes hybridized with I-CeuI chromosomal fragments were also recognized by a probe specific for 16S rDNA, suggesting a chromosomal location. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that a major outer membrane protein, OmpF, was absent in all isolates. PFGE of XbaI-digested DNA were considered to be unrelated. The results of our study suggest that the chromosomal AmpC β-lactamase with impermeability in E. cloacae clinical isolates implicated in reduced carbapenem susceptibility. Although carbapenem-resistant E. cloacae isolates were isolated in a few patients in our study, the clinical outcomes were grave. Therefore, the patients colonized or infected by carbapenemresistant E. cloacae isolates should gain attention of antibiotic therapy.

UR - http://www.scopus.com/inward/record.url?scp=84868664237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868664237&partnerID=8YFLogxK

M3 - Article

C2 - 22964616

AN - SCOPUS:84868664237

VL - 42

SP - 281

EP - 286

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 3

ER -